The adequate intake is like the RDA, but based on weaker evidence
Other recognised side effects include: Fatigue and dizziness, particularly during the initial weeks of treatment Headache, classified as 'common' in product information Hypoglycaemia (low blood sugar), primarily a risk in patients also taking insulin or sulfonylureas
Was an adverse event missed in clinical trials
and broader cardiovascular pathology [17, 113]
Pharmaceutical-grade Retatrutide Raw Powder typically arrives in amber glass vials or aluminum foil-wrapped packaging that blocks light transmission
AUTHORS CONTRIBUTIONS All authors contributed greatly to the success of this work CONFLICT OF INTEREST No conflict of interest to declare in this manuscript ACKNOWLEDGEMENT This case was carried out without direct funding, and the authors would like to thank the Head and the entire staffs of the Department of Human Physiology, College of Medical Sciences, Ahmadu Bello University, Zaria, for their support and provision of necessary facilities